March 27–28 2017, Institut Curie, Paris

Scientific Program > Invited Speakers

  • Lionel Apetoh, French National Institute of Health and Medical Research (Inserm), France
    • Immunogenic tumor cell death and its relevance for cancer treatment
  • Georg Bauer, University of Freiburg, Germany
    • Targeting protective catalase of tumor cells with cold atmospheric plasma-treated medium
  • Anne-Laure Bulteau, University of Lyon, France
    • Mechanistic insights into the impact of cold atmospheric pressure plasma on human epithelial cell lines
  • Jerome Canady, US Medical Innovations LLC, United States of America
    • Clinical application of cold atmospheric plasma (CAP) and hybrid plasma for the treatment of stage IV gastrointestinal cancers: update
  • Cristina Canal, University of Catalonia, Spain
    • Plasma jet selectivity on bone cancer cells and liquid-mediated effects
  • Anthony Delalande, University of Orléans, France
    • Investigation of cell membrane permeabilization induced by plasma treatment for drug delivery applications
  • Marie Dutreix, Institut Curie, France
    • DNA repair inhibitors: story of the Dbait discovery from bench to bed
  • Yuri Gorbanev, University of Antwerp, Belgium
    • Analysis of plasma-exposed aqueous solutions: Reactive plasma regions as sources of RONS
  • Georg Isbary, Roche Pharma AG, Germany
    • Oncology - from pharmaceutical view
  • Norman Maitland, University of York, United Kingdom
    • Mechanisms of cell death in normal and malignant prostate epithelial cells after treatment with low temperature plasma
  • Fatima Mechta-Grigoriou, Institut Curie, France
    • Role of miR-200 and stromal heterogeneity in ovarian and breast tumours
  • Nofel Merbahi, University of Toulouse, France
    • Plasma activated medium induce head and neck FaDu cancer cell death
  • Hans-Robert Metelmann, University of Greifswald, Germany
    • Head and neck cancer treatment with plasma – clinical experience to support basic research with practical plasma application data
  • Yoshimichi Nakatsu, Kyushu University, Japan
    • Analyses of oxidative mutagenesis and carcinogenesis using genetically modified mice: application to plasma medicine
  • Ryo Ono, University of Tokyo, Japan
    • Immunotherapy of melanoma in mice using nanosecond pulsed streamer discharge
  • Christian Seebauer, University of Greifswald, Germany
    • Therapeutic potential of cold atmospheric plasma for the treatment of leukoplakia as intraoral precancerous lesion
  • Robert Short, University of Lancaster, United Kingdom
    • The effect of plasma treated media on chromosomal modification in cell division
  • Colin Young, George Washington University, United States of America
    • Intracranial targeting of glioblastoma multiforme with cold atmospheric plasma
Online user: 1 RSS Feed